Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Euralis is a leading French agricultural and food cooperative group, established in 1936 and headquartered in Lescar. The company is a major player in the life sciences sector, particularly through its Seeds division, Lidea, which specializes in plant biotechnology, genomics, and the development of high-performance seed varieties. Euralis invests significantly in R&D to enhance crop traits such as yield, drought resistance, and disease tolerance for major species including maize, sunflower, and rapeseed. Beyond seeds, the group is a global leader in the gastronomy sector, notably through its foie gras brands like Rougié and Maison Montfort. The company also focuses on sustainable energy and regenerative agriculture initiatives to support its 9,000 farmer members. Euralis operates internationally with a presence in 16 countries and a strong focus on the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Euralis.